eli lilly's tirzepatide is the leader in weight loss sector battle over the trillion-dollar weight-loss bonanza Diabetes drug tested for weight

Effect size guidelines, sample size calculations, and statistical power in gerontology

Diabetes Care

Available Brands and Semaglutide Dosing Differences Semaglutide is manufactured by Novo Nordisk and is available under different brand names, each with specific FDA-approved uses and dosing schedules

The results from the sensitivity analyses accounting for either the full population of SURPASS2 (sensitivity analysis 1), the full population of both trials (sensitivity analysis 2), the treatmentregimen estimand in the full population of both trials (sensitivity analysis 3) or the adjusted baseline HbA1c and body weight in the full population of both trials (sensitivity analysis 4) were consistent with those of the primary analysis (Figure 2A)

Glycaemic efficacy Compared with placebo, tirzepatide 15 mg was the most efficacious treatment in reducing HbA 1c (MD [95% CI]: 21.61 mmol/mol [23.26 to 19.97] [1.96% (2.11 to 1.82)]), followed by tirzepatide 10 mg (20.19 mmol/mol [21.89 to 18.48] [1.84% (1.99 to 1.69)]), semaglutide 2.0 mg (17.74 mmol/mol [22.03 to 13.45] [1.59% (1.95 to 1.22)]), tirzepatide 5 mg (17.60 mmol/mol [19.36 to 15.84] [1.60% (1.75 to 1.44)]), semaglutide 1.0 mg (15.25 mmol/mol [16.73 to 13.77] [1.39% (1.52 to 1.26)]) and semaglutide 0.5 mg (12.00 mmol/mol [13.74 to 10.26] [1.09% (1.24 to 0.94)]) (Fig

Recent shortages have frustrated patients, proving that logistics are as critical as innovation